Sljedeći

Auto Play

Kidney cancer: post-surgery sorafenib

0 Pogledi • 06/26/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Tim Eisen, MBBChir, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, describes the rationale and methodology behind the SORCE trial (NCT00492258) and what have we learned at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play